A systematic review of the quality of reporting and risk of bias for randomized crossover trials in digestive disease journals.

Qian ZhouZhi-Hang ChenJin-Xin ZhangSui Peng

Published in: Therapeutic advances in gastroenterology (2022)

These findings demonstrated the inadequate quality of randomized crossover trials for digestive diseases. Compliance with the CONSORT extension for crossover trials must be strengthened and improved (PROSPERO CRD: 42021248723).

Keyphrases

double blind
placebo controlled
open label
phase iii
clinical trial
phase ii
study protocol
randomized controlled trial
adverse drug
meta analyses